Hebrew University of Jerusalem launched 15 spinouts last year covering areas ranging from healthcare to solar energy.
Yissum, the technology transfer arm of Hebrew University of Jerusalem, launched a total of 15 spinouts last year.
The companies are:
- RNAWay, which has developed a platform for delivering siRNA to plants;
- Immunyx Pharma, which is working on technology for neutrophil specific targeting a mode of immunotherapy;
- Lipovac, which has set its sights on a liposome-based vaccine to treat conditions including covid;
- ExoNavis Therapeutics, which is focusing on exosome-based drug delivery;
- NexoCarp, which is pickering solid dispersion and particles for the delivery of agents;
- PSYRX,…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
